- Advocacy
- AI & Biomarkers
- Clinical topics - optimizing clinical trials, regulatory issues, novel combinations
- DNA damager response
- Metastasis
- Microenvironment
- Omics & Epigenetics
- Plasticity / Heterogeneity / Resistance
- Predisposition / Genetics / Prevention
